Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2011 (2011), Article ID 656030, 7 pages
http://dx.doi.org/10.1155/2011/656030
Clinical Study

Determinants of Intravascular Resistance in Indian Diabetic Nephropathy Patients: A Hospital-Based Study

1Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India
2Department of Radiodiagnosis, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India

Received 31 January 2011; Revised 8 April 2011; Accepted 12 April 2011

Academic Editor: Marc A. Passman

Copyright © 2011 Anubhav Thukral et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. E. Ayodele, C. O. Alebiosu, and B. L. Salako, “Diabetic nephropathy—a review of the natural history, burden, risk factors and treatment,” Journal of the National Medical Association, vol. 96, no. 11, pp. 1445–1454, 2004. View at Google Scholar · View at Scopus
  2. M. K. Mani, “Patterns of renal disease in indigenous populations in India,” Nephrology, vol. 4, supplement, pp. S4–S7, 1998. View at Google Scholar · View at Scopus
  3. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Google Scholar · View at Scopus
  4. P. Kimmelstiel and C. Wilson, “Intercapillary lesions in the glomeruli of the kidney,” American Journal of Pathology, vol. 12, no. 1, pp. 83–98, 1936. View at Google Scholar
  5. J. S. Cameron, “The discovery of diabetic nephropathy: from small print to centre stage,” Journal of Nephrology, vol. 19, no. 10, supplement, pp. S75–S87, 2006. View at Google Scholar · View at Scopus
  6. R. Nosadini, M. Velussi, E. Brocco et al., “Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate,” Diabetes, vol. 49, no. 3, pp. 476–484, 2000. View at Google Scholar · View at Scopus
  7. R. Zatz, T. W. Meyer, H. G. Rennke, and B. M. Brenner, “Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 17, pp. 5963–5967, 1985. View at Google Scholar · View at Scopus
  8. R. Bright, “Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine,” Guy’s Hospital Reports, vol. 1, no. 1, pp. 338–400, 1836. View at Google Scholar
  9. M. A. Gall, P. Hougaard, K. Borch-Johnsen, and H. H. Parving, “Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study,” British Medical Journal, vol. 314, no. 7083, pp. 783–788, 1997. View at Google Scholar · View at Scopus
  10. C. E. Mogensen, “Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes,” The New England Journal of Medicine, vol. 310, no. 6, pp. 356–360, 1984. View at Google Scholar · View at Scopus
  11. G. C. Viberti, R. J. Jarrett, and R. D. Hill, “Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus,” The Lancet, vol. 1, no. 8287, pp. 1430–1432, 1982. View at Google Scholar · View at Scopus
  12. M. L. Caramori, P. Fioretto, and M. Mauer, “Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions,” Diabetes, vol. 52, no. 4, pp. 1036–1040, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Steinke, A. R. Sinaiko, M. S. Kramer, S. Suissa, B. M. Chavers, and M. Mauer, “The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients,” Diabetes, vol. 54, no. 7, pp. 2164–2171, 2005. View at Publisher · View at Google Scholar
  14. H. J. Kramer, Q. D. Nguyen, G. Curhan, and C. Y. Hsu, “Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 289, no. 24, pp. 3273–3277, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. H. H. Parving, N. Chaturvedi, G. Viberti, and C. E. Mogensen, “Does microalbuminuria predict diabetic nephropathy?” Diabetes Care, vol. 25, no. 2, pp. 406–407, 2002. View at Google Scholar · View at Scopus
  16. B. A. Perkins, L. H. Ficociello, K. H. Silva, D. M. Finkelstein, J. H. Warram, and A. S. Krolewski, “Regression of microalbuminuria in type 1 diabetes,” The New England Journal of Medicine, vol. 348, no. 23, pp. 2285–2293, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. H. H. Otu, H. Can, D. Spentzos et al., “Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy,” Diabetes Care, vol. 30, no. 3, pp. 638–643, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. B. A. Perkins, R. G. Nelson, B. E. P. Ostrander et al., “Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1404–1412, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. D. Ellis, K. Y. Z. Forrest, J. Erbey, and T. J. Orchard, “Urinary measurement of transforming growth factor-β and type IV collagen as new markers of renal injury: application in diabetic nephropathy,” Clinical Chemistry, vol. 44, no. 5, pp. 950–956, 1998. View at Google Scholar · View at Scopus
  20. R. H. Noth, A. Krolewski, G. A. Kaysen, T. W. Meyer, and M. Schambelan, “Diabetic nephropathy: hemodynamic basis and implications for disease management,” Annals of Internal Medicine, vol. 110, no. 10, pp. 795–813, 1989. View at Google Scholar · View at Scopus
  21. World Health Organization, “Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus,” World Health Organization Department of Non communicable Disease Surveillance, Geneva, Switzerland, 1999.
  22. E. Ishimura, Y. Nishizawa, T. Kawagishi et al., “Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography,” Kidney International, vol. 51, no. 6, pp. 1920–1927, 1997. View at Google Scholar · View at Scopus
  23. S. H. Kim, H. Kim, S. Y. Kim et al., “Usefulness of R.I. and P.I. in patient with diabetic nephropathy as early markers,” Korean Journal of Nephrology, vol. 19, no. 5, pp. 876–883, 2000. View at Google Scholar
  24. K. Hamano, A. Nitta, T. Ohtake, and S. Kobayashi, “Associations of renal vascular resistance with albuminuria and other microangiopathy in type 2 diabetic patients,” Diabetes Care, vol. 31, no. 9, pp. 1853–1857, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. Ljubiæ, B. Brkljaèiæ, Z. Metelko, and I. P. Renar, “Renal resistance index in type 2 diabetes,” Diabetologia Croatica, vol. 35, no. 1, pp. 7–13, 2006. View at Google Scholar · View at Scopus
  26. Y. Ohta, K. Fuj II, H. Arima et al., “Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography,” Journal of Hypertension, vol. 23, no. 10, pp. 1905–1911, 2005. View at Google Scholar · View at Scopus
  27. F. Pistrosch, K. Herbrig, B. Kindel, J. Passauer, S. Fischer, and P. Gross, “Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients,” Diabetes, vol. 54, no. 7, pp. 2206–2211, 2005. View at Publisher · View at Google Scholar · View at Scopus